Kite and Shoreline Enter $2.3 Billion Agreement to Develop Novel Cell Therapies
Kite, a Gilead Company, and Shoreline Biosciences have announced a $2.3 Billion strategic partnership to develop novel cell therapies across
Read moreKite, a Gilead Company, and Shoreline Biosciences have announced a $2.3 Billion strategic partnership to develop novel cell therapies across
Read moreDanish multinational pharmaceutical company Novo Nordisk and Japanese cardiac regenerative medicine specialist Heartseed have confirmed an exclusive global partnership and license
Read moreCharles River Laboratories International confirmed signing a definitive contract to acquire Vigene Biosciences, a leading gene therapy contract development and manufacturing
Read moreEli Lilly and Company and MiNA Therapeutics, a pioneer in RNA activation therapeutics, have announced a worldwide research partnership to
Read moreLow-income countries can benefit from the latest Moderna – Gavi agreement, which is set up to distribute up to 500
Read morePfizer announced on Wednesday, the acquisition of Amplyx Pharmaceuticals, Inc., a privately-owned company focused on the engineering of treatments for
Read moreThermo Fisher Scientific expands clinical research service offering to pharma and biotech customers with a CRO giant PPD acquisition. Thermo
Read moreFrench pharma giant Sanofi is set to acquire Tidal Therapeutics for $470m, adding the biotech’s novel mRNA-based research platform with
Read moreThe Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Panacea Biotec, India’s largest vaccine and pharmaceutical manufacturer, have
Read moreContract Development and Manufacturing Organization Celonic and German biopharmaceutical company CureVac have entered into an agreement to manufacture 100 Million
Read more